Squarepoint
PLSE icon

Squarepoint’s Pulse Biosciences PLSE Stock Holding History

Squarepoint’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,418
Closed -$827K – 4935
2025
Q1 		$827K Buy
+51,418
New +$958K ﹤0.01% 2838
2024
Q4 		– Sell
-16,227
Closed -$285K – 5398
2024
Q3 		$285K Buy
+16,227
New +$277K ﹤0.01% 3479
2023
Q4 		– Sell
-19,524
Closed -$78.7K – 4378
2023
Q3 		$78.7K Buy
19,524
+5,995
+44% +$37.3K ﹤0.01% 3594
2023
Q2 		$97.3K Buy
+13,529
New +$86.4K ﹤0.01% 3367
2020
Q3 		– Sell
-43,278
Closed -$453K – 2764
2020
Q2 		$453K Buy
+43,278
New +$390K 0.01% 1365
2018
Q1 		– Sell
-9,690
Closed -$229K – 2042
2017
Q4 		$229K Buy
+9,690
New +$229K ﹤0.01% 1718

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Squarepoint's PLSE Position: Q2 2025 in Review

Squarepoint sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 51,418 shares — an estimated $827K sold.

Squarepoint first reported a position in PLSE in Q4 2017 and held it in 6 quarters. The position peaked at $827K in Q1 2025. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

  • Squarepoint reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 51,418 Pulse Biosciences shares in Q2 2025, an estimated $827K.
  • Squarepoint first reported a position in Pulse Biosciences in Q4 2017 and held it in 6 quarters.
  • Squarepoint's Pulse Biosciences position peaked at $827K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.